Burden of Primary Biliary Cholangitis Among Inpatient Population in the United States
- PMID: 30859148
- PMCID: PMC6396368
- DOI: 10.1002/hep4.1314
Burden of Primary Biliary Cholangitis Among Inpatient Population in the United States
Abstract
Primary biliary cholangitis (PBC) is an autoimmune liver disease that can lead to cirrhosis and liver failure. Our aim was to assess the recent trends in the mortality rates and health care utilization of patients with PBC seen in the inpatient setting in the United States. We used the National (Nationwide) Inpatient Sample data (2005-2014). The study population included adults with PBC, using International Classification of Diseases, Ninth Revision codes. Trends in PBC-related discharges, total charges, length of stay (LoS), and in-hospital mortality were evaluated. Hierarchical generalized linear models were performed for determining predictors of mortality and total hospital charges. Between the study years of 2005 and 2014, a total of 22,665 hospitalized cases with PBC were identified (mean age 63 years; 84% female, 76% white). The number of PBC-related discharges increased from 3.24 per 100,000 in 2005 to 3.68 per 100,000 in 2014, with an average annual increase of 1.4% (95% confidence interval [CI]: 0.4%-2.4%). Fifty-seven percent had Medicare as their primary payer, 37% had cirrhosis, and 1.3% had hepatocellular carcinoma. Between 2005 and 2014, the average total charges for PBC increased from $53,901 to $57,613 (annual percent change [APC], 1.7%; 95% CI: -0.2%-3.5%), LoS decreased from 6.9 days to 5.4 days (APC, -2.2%; 95% CI: -3.2% to -1.1%), and mortality rate decreased from 3.8% to 2.8% (APC, -5.4%; 95% CI: -8.4% to -2.4%). Multivariable analysis revealed that ascites were independently associated with increased risk of in-hospital mortality (odds ratio: 1.77; 95% CI: 1.50-2.08), increased charge (percent change: 22.5%; 95% CI: 18.6%-26.7%), and increased LoS (percent change: 29.7%; 95% CI: 25.7%-33.9%). Conclusion: The number of PBC cases has increased in recent years. Mortality and LoS have decreased, and the total charges have remained the same.
Figures
Similar articles
-
Characteristics and Inpatient Outcomes of Primary Biliary Cholangitis and Autoimmune Hepatitis Overlap Syndrome.J Clin Transl Hepatol. 2021 Jun 28;9(3):392-398. doi: 10.14218/JCTH.2021.00008. Epub 2021 Mar 11. J Clin Transl Hepatol. 2021. PMID: 34221925 Free PMC article.
-
Primary Biliary Cholangitis in Medicare Population: The Impact on Mortality and Resource Use.Hepatology. 2019 Jan;69(1):237-244. doi: 10.1002/hep.30174. Hepatology. 2019. PMID: 30015376
-
Trends of autoimmune liver disease inpatient hospitalization and mortality from 2011 to 2017: A United States nationwide analysis.World J Hepatol. 2024 Jul 27;16(7):1029-1038. doi: 10.4254/wjh.v16.i7.1029. World J Hepatol. 2024. PMID: 39086532 Free PMC article.
-
Gender and Racial Differences in Hospitalizations for Primary Biliary Cholangitis in the USA.Dig Dis Sci. 2021 May;66(5):1461-1476. doi: 10.1007/s10620-020-06402-3. Epub 2020 Jun 13. Dig Dis Sci. 2021. PMID: 32535779
-
Incidence and risk factors for hepatocellular carcinoma in primary biliary cirrhosis.Clin Rev Allergy Immunol. 2015 Jun;48(2-3):132-41. doi: 10.1007/s12016-015-8483-x. Clin Rev Allergy Immunol. 2015. PMID: 25762349 Review.
Cited by
-
Characteristics and Inpatient Outcomes of Primary Biliary Cholangitis and Autoimmune Hepatitis Overlap Syndrome.J Clin Transl Hepatol. 2021 Jun 28;9(3):392-398. doi: 10.14218/JCTH.2021.00008. Epub 2021 Mar 11. J Clin Transl Hepatol. 2021. PMID: 34221925 Free PMC article.
-
Demographic Trends in Liver Transplant Survivors After 3 Decades of Program Implementation: The Impact of Cohort and Period Effects on Life Expectancy.Transplant Direct. 2024 Jul 29;10(8):e1684. doi: 10.1097/TXD.0000000000001684. eCollection 2024 Aug. Transplant Direct. 2024. PMID: 39081590 Free PMC article.
-
Race/Ethnicity and Insurance-Specific Disparities in In-Hospital Mortality Among Adults with Primary Biliary Cholangitis: Analysis of 2007-2014 National Inpatient Sample.Dig Dis Sci. 2020 Feb;65(2):406-415. doi: 10.1007/s10620-019-05809-x. Epub 2019 Sep 5. Dig Dis Sci. 2020. PMID: 31489564
-
Two Decades of Liver Transplants for Primary Biliary Cholangitis: A Comparative Study of Living Donors vs. Deceased Donor Liver Transplantations.J Clin Med. 2023 Oct 15;12(20):6536. doi: 10.3390/jcm12206536. J Clin Med. 2023. PMID: 37892674 Free PMC article.
-
Decreasing Rates of Fracture-Related Hospitalization With Primary Biliary Cholangitis: Insights From the Nationwide Inpatient Sample.Cureus. 2022 May 14;14(5):e25001. doi: 10.7759/cureus.25001. eCollection 2022 May. Cureus. 2022. PMID: 35719819 Free PMC article.
References
-
- Imam MH, Lindor KD. The natural history of primary biliary cirrhosis. Semin Liver Dis 2014;34:329‐333. - PubMed
-
- Selmi C, Bowlus CL, Gershwin ME, Coppel RL. Primary biliary cirrhosis. Lancet 2011;377:1600‐1609. - PubMed
-
- Zhang H, Carbone M, Lleo A, Invernizzi P. Geoepidemiology, genetic and environmental risk factors for PBC. Dig Dis 2015;33(Suppl. 2):94‐101. - PubMed
-
- Prince M, Chetwynd A, Newman W, Metcalf JV, James OFW. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow‐up for up to 28 years. Gastroenterology 2002;123:1044‐1051. - PubMed
-
- Boonstra K, Kunst AE, Stadhouders PH, Tuynman HA, Poen AC, van Nieuwkerk KMJ, et al. Rising incidence and prevalence of primary biliary cirrhosis: a large population‐based study. Liver Int 2014;34:e31‐e38. - PubMed
LinkOut - more resources
Full Text Sources